Main Menu
Menu

Resources

Publish Date
Resources
Public Comments
C4IP Comments RE: Requirement to Identify All Real Parties in Interest to a Third Party Request for an Ex Parte Reexamination (PTO-P-2025-0545)
Council for Innovation Promotion
Resources
Letters
C4IP Letter to Senate Judiciary Committee RE: Hearing on Patent Eligibility
Council for Innovation Promotion
Resources
Infographics
Idea Factories Report Infographic
Council for Innovation Promotion
Resources
Issue Briefs
Congress Should Pass PERA to Fix What the Supreme Court Unintentionally Broke
Council for Innovation Promotion
Resources
Public Comments
C4IP Comments RE: The Section 301 Investigation of Vietnam’s Acts, Policies, and Practices Related to Intellectual Property Protection (USTR-2026-0364)
Council for Innovation Promotion
Resources
Public Comments
C4IP Comments RE: The Section 301 Investigation of Brazil’s Acts, Policies, and Practices Related to Intellectual Property Protection (USTR-2026-0331)
Council for Innovation Promotion
Resources
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Hearing on IP and the Internet
Council for Innovation Promotion
Resources
Letters
C4IP Letter to Senate Finance Committee RE: Nomination of Peter-Anthony Pappas to the U.S. International Trade Commission
Council for Innovation Promotion
Resources
Letters
C4IP Letter to Senate HELP Committee RE: Consideration of Medication Affordability and Patent Integrity Act
Council for Innovation Promotion
C4IPResources
Letters
C4IP Letter to Senate HELP Committee RE: Medication Affordability and Patent Integrity Act Markup
Council for Innovation Promotion
Resources
External ResourcesReports
Idea Factories: How Intellectual Property Sustains and Cultivates Technology Ecosystems
Professor Jonathan Barnett
Resources
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Hearing on Medicines and IP
Council for Innovation Promotion
Resources:

Resources:

C4IP Comments RE: Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings before the Patent Trial and Appeal Board (PTO–P–2020–0022),

06/20/2023
Resources:

Resources:

C4IP Public Interest Comments RE: ITC Inv. No. 337-TA-1276 – Certain Light-Based Physiological Measurement Devices and Components Thereof,

06/05/2023
Resources:

Resources:

C4IP Letter to House Ways & Means Subcommittee on Health RE: Hearing on Medical Innovation and Patient Access,

05/10/2023
Resources:

Resources:

C4IP Written Submission for Inv. No. 332-596,

04/26/2023
Resources:

Resources:

Public Comments on European Commission Draft SEP Regulation,

04/19/2023
Resources:

Resources:

C4IP Response to CMS Solicitation of Comments Concerning Initial Guidance on the Inflation Reduction Act’s (IRA) Medicare Drug Negotiation Program,

04/14/2023
Resources:

Resources:

C4IP Post-Hearing Brief RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023
Resources:

Resources:

C4IP Testimony RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023
Resources:

Resources:

C4IP Letter to Senate HELP Committee RE: The Bayh-Dole Act and 28 U.S. Code § 1498,

03/17/2023
Resources:

Resources:

C4IP Comments RE: Joint USPTO-FDA Collaboration Initiatives (PTO-P-2022-0037),

03/10/2023
Resources:

Resources:

C4IP Comments RE: Certain Light-Based Physiological Measurement Devices and Components Thereof (337-TA-1276),

02/23/2023
Resources:

Resources:

C4IP Comments RE: Request for Comments on USPTO Initiatives To Ensure the Robustness and Reliability of Patent Rights (PTO-P-2022-0025),

01/31/2023
Scroll to Top